Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer

被引:183
|
作者
Madalinska, JB
Hollenstein, J
Bleiker, E
van Beurden, M
Valdimarsdottir, HB
Massuger, LF
Gaarenstroom, KN
Mourits, MJE
Verheijen, RHM
van Dorst, EBL
van der Putten, H
van der Velden, K
Boonstra, H
Aaronson, NK
机构
[1] Netherlands Canc Inst, Dept Gynecol, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Dept Gynaecol, Amsterdam, Netherlands
[3] Acad Med Ctr, Dept Gynecol, Amsterdam, Netherlands
[4] Univ Nijmegen, Med Ctr, Dept Gynecol, Nijmegen, Netherlands
[5] Leiden Univ, Med Ctr, Dept Gynecol, Leiden, Netherlands
[6] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol, Groningen, Netherlands
[7] Univ Utrecht, Med Ctr, Dept Gynecol, Utrecht, Netherlands
[8] Acad Hosp Maastricht, Dept Gynecol, Maastricht, Netherlands
[9] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
关键词
D O I
10.1200/JCO.2005.02.626
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Recommendations for women at high risk of ovarian cancer include periodic gynecologic screening (GS) and prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to determine the quality-of-life (QOL) effects of PBSO versus GS. Patients and Methods: Questionnaire data were obtained from 846 high-risk women who had participated in this nationwide, cross-sectional, observational study. Forty-four percent of the women had undergone PBSO, and 56% had opted for GS. Topics addressed by the questionnaire included generic QOL, cancer-specific distress, endocrine symptoms, and sexual functioning. Results: No statistically significant between-group differences were observed in generic QOL (Short Form-36), with women in both the PBSO and GS groups scoring similarly to the general population. Compared with GS, PBSO was associated with fewer breast and ovarian cancer worries (P < .001) and more favorable cancer risk perception (P < .05). However, the PBSO group reported significantly more endocrine symptoms (P < .001) and worse sexual functioning (P < .05) than the GS group. Eighty-six percent of women would choose PBSO again, and 63% would recommend it to a friend with familial risk of ovarian cancer. Conclusion: PBSO had no measurable adverse impact on generic QOL of high-risk women. The favorable effects of PBSO in terms of reduced cancer worries and low perceived cancer risk need to be weighed against the increase in endocrine and sexual symptoms. Balanced information will help clinicians and high-risk women to make informed decisions about the optimal preventive health strategy. © 2005 by American Society of Clinical Oncology.
引用
收藏
页码:6890 / 6898
页数:9
相关论文
共 50 条
  • [21] The impact of bilateral salpingo-oophorectomy on sexuality and quality of life in women with breast cancer
    Paige E. Tucker
    Paul A. Cohen
    Max K. Bulsara
    Stephanie Jeffares
    Christobel Saunders
    [J]. Supportive Care in Cancer, 2021, 29 : 369 - 375
  • [22] The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy
    Bresser, P. J. C.
    Seynaeve, C.
    Van Gool, A. R.
    Niermeijer, M. F.
    Duivenvoorden, H. J.
    van Dooren, S.
    van Geel, A. N.
    Menke-Pluijmers, M. B.
    Klijn, J. G. M.
    Tibben, A.
    [J]. EUROPEAN JOURNAL OF CANCER, 2007, 43 (01) : 95 - 103
  • [23] Pathologic findings at risk-reducing salpingo-oophorectomy among women at increased ovarian cancer risk: Results from GOG-199.
    Mai, Phuong L.
    Sherman, Mark E.
    Piedmonte, Marion
    Ioffe, Olga B.
    Ronnett, Brigitte M.
    Van Le, Linda
    Mutch, David Gardner
    Cohn, David E.
    Thigpen, J. Tate
    Tewari, Krishnansu Sujata
    Disilvestro, Paul
    Kauff, Noah D.
    Lu, Karen H.
    Greene, Mark H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Coronary Heart Disease Risk Profile in Women Who Underwent Salpingo-Oophorectomy to Prevent Hereditary Breast Ovarian Cancer
    Michelsen, Trond Melbye
    Tonstad, Serena
    Pripp, Are H.
    Trope, Claes G.
    Dorum, Anne
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (02) : 233 - 239
  • [25] Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review
    Park, Sun-Young
    Kim, Youlim
    Kim, Sue
    [J]. KOREAN JOURNAL OF WOMEN HEALTH NURSING, 2020, 26 (04): : 285 - 299
  • [26] A prospective study of risk-reducing salpingo-oophorectomy and longitudinal CA-125 screening among women at increased genetic risk of ovarian cancer: Design and baseline characteristics: A Gynecologic oncology group study
    Greene, Mark H.
    Piedmonte, Marion
    Alberts, Dave
    Gail, Mitchell
    Hensley, Martee
    Miner, Zoe
    Mai, Phuong L.
    Loud, Jennifer
    Rodriguez, Gustavo
    Basil, Jack
    Boggess, John
    Schwartz, Peter E.
    Kelley, Joseph L.
    Wakeley, Katie E.
    Minasian, Lori
    Skates, Stephen
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (03) : 594 - 604
  • [27] Sexual activity and functioning in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer
    Michelsen, T. M.
    Dahl, A. A.
    Trope, C.
    Dorum, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer
    Manchanda, Ranjit
    Drapkin, Ronny
    Jacobs, Ian
    Menon, Usha
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 185 - 191
  • [29] Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer
    Fakkert, Ingrid E.
    Abma, Elske Marije
    Westrik, Iris G.
    Lefrandt, Joop D.
    Wolffenbuttel, Bruce H. R.
    Oosterwijk, Jan C.
    Slart, Riemer H. J. A.
    van der Veer, Eveline
    de Bock, Geertruida H.
    Mourits, Marian J. E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (03) : 400 - 408
  • [30] Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer
    Fakkert, Ingrid E.
    van der Veer, Eveline
    Abma, Elske Marije
    Lefrandt, Joop D.
    Wolffenbuttel, Bruce H. R.
    Oosterwijk, Jan C.
    Slart, Riemer H. J. A.
    Westrik, Iris G.
    de Bock, Geertruida H.
    Mourits, Marian J. E.
    [J]. PLOS ONE, 2017, 12 (01):